Garry Arthur Neil - 09 Jun 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Signature
/s/ Christopher Sullivan, by Power of Attorney
Issuer symbol
AVTX
Transactions as of
09 Jun 2023
Net transactions value
+$13,680
Form type
4
Filing time
13 Jun 2023, 16:39:36 UTC
Previous filing
22 May 2023
Next filing
20 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $13,680 +4,000 +43% $3.42* 13,220 09 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.